A Federal Court judge has rejected a revised pleading in a class action against Ford over its allegedly defective PowerShift transmissions.
The Australian Workers Union has called on the Federal Court to toss AstraZeneca’s challenge to a decision that workers are guaranteed 10 days’ sick leave regardless of how long their working day is.
A class action against Westpac over allegedly excessive insurance premiums has been put on ice after funder JustKapital filed an application to stay the case in the wake of the bank’s appeal challenging the court’s power to make a common fund order.
Quinn Emanuel has filed a class action against Volkswagen over cars fitted with defective Takata airbags, the seventh class action filed by the firm in what’s been touted as one the largest consumer class actions in Australia.
ASIC has been given a little over a month to provide ANZ with documents it collected during the course of its investigation into a $2.5 billion ANZ share placement, as the bank, which is facing a related criminal cartel case, mulls whether to file an application to stay the regulator’s action.
Westpac is contesting a subpoena in a class action over allegedly excessive life insurance premiums for documents from Deloitte that may reveal how the bank chose the policies it offered.
A NSW Supreme Court judge said Monday it will refer to the Court of Appeal a challenge by car giant BMW to a common fund order proposed by law firm Quinn Emanuel Urquhart & Sullivan for its six class actions over Takata airbags.
Bannister Law has withdrawn from a class action it filed against Ford over allegedly defective Powershift transmissions following a dispute between the firm and the litigation funder that’s backing the case.
The litigation funder at the centre of a challenge by Westpac to the Federal Court’s power to make common fund orders faced a fiery judge in a tense exchange Friday, after it revealed it was weighing a bid to pause a class action against the bank until after the appeal.
The High Court has dismissed the ACCC’s bid to appeal a Full Federal Court decision upholding a ruling that drug giant Pfizer did not misuse its market power in the months leading up to the expiration of the patent for its blockbuster cholesterol drug Lipitor.